Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy

New England Journal of Medicine 2026

View at publisher

Authors: P. Singh, Seth P. Lerner

DOI: 10.1056/nejme2515777

Cited by: 3

References: 6

Fields of Study & Subjects

Colorectal and Anal Carcinomas Hidradenitis Suppurativa and Treatments Cancer Immunotherapy and Biomarkers

References 6